Healthy Heart Program

If you are already suffering from cardiovascular disease or have identified risk factors and wish to reduce those risks, IHA has many methods to address to your health concerns. Your program is individually tailored to your needs and may include recommendations of appropriate nutrient supplements, diet and lifestyle programs , anti-oxidant therapies and treatments such as chelation therapy.

Chelation Therapy
Chelation Therapy is a safe, effective and relatively inexpensive treatment to restore blood flow in cases of atherosclerosis without surgery. Chelation therapy involves the intravenous infusion of vitamins, magnesium, saline solution and an amino acid, EDTA (ethylene diamine tetracetic acid). The intravenous solution is slowly trickled into the bloodstream and seeks out toxic metals in the body such as lead, cadmium, and aluminum. Gradually over time, it improves the macro and micro-circulation to the extremities, heart, and other internal organs. There are over 60,000 miles of blood vessels in the body. Improvement in their function will benefit all the organ systems in the body due to increased blood flow at the micro-circulation level.

Chelation therapy practice is certified and monitored in BC by the Association of Naturopathic Physicians of British Columbia through the Naturopathic Council for Chelation Certification. Lab technicians are trained and certified by ACAM through the International Society of Chelation Technicians. The doctors at Integrative Healing Arts utilizing Chelation therapy are properly trained in using the ACAM protocols for Chelation therapy and insuring the safety of our patients.

I.V. Phosphatidylcholine Therapy
A recent change to chelation therapy protocols for cardiovascular disease at IHA has been the inclusion of I.V.phosphatidylcholine therapy, alternating 2:1 with EDTA chelation. Phosphatidylcholine Therapy is a new non-surgical Swiss treatment protocol for angina pectoris sufferers and arterial blockages.

A few years ago, physicians stumbled onto a generic product isolated from soy beans which had been tested clinically 20 years prior to treatment of patients severely ill with coronary artery disease. 20 patients suffering from irreversible angina pectoris pain and being sustained on beta blockers and nitroglycerine products were entered into the program which consisted of the infusion over a period of 50-60 minutes of the above solution 3-5 times per week for a total of 30 treatments.

To the amazement of the researchers, 19 patients who finished the treatment protocol were completely asymptomatic and free of medication. One patient dropped out at the beginning of the program for no reason.

The most important effect of Phosphatidylcholine is its remarkable ability to reduce plaque depositions in the arterial walls. It also lowers cholesterol and homocysteine levels. Studies in lab animals have shown that it increase their life span by up to 36%.

An important therapeutic application of the Phosphatidylcholine treatment program is increasing and individual's ability to withstand cardiac stress. This application is valuable for the individuals who have suffered cardiac trauma, such as myocardial infarction or who are at high risk of heart trauma.

Effect of Phosphatidylcholine (PC)

PC reduces Angina Pectoris pain and frequency of attacks
PC lowers LDL Cholesterol
PC increases HDL Cholesterol
PC improves walking distance
PC improves sexual potency
PC Improves Brain Function
Phosphatidylcholine is useful in the treatment of patients with angina pectoris, with reduced blood flow to the brain and extremities and prophylactically in the treatment against fat embolus and strokes.

Ben Boucher M.D., of Cape Breton, N.S. asserts that the buildup of metals in our bodies causes free radical oxidation, which damages cells. He explained in a Medical Post report that when the cells of the artery walls are damaged, cholesterol accumulated, strangling circulation. Boucher believes that Chelation therapy can reverse the effects of free-radical oxidation, allowing oxygen and nutrient rich blood to flow freely through the arteries. A Finnish study also links heart disease to excessive amounts of iron stored in the body. Chelation therapy pulls excess iron out of the human system.

Bypassing Bypass Surgery
Elmer Cranton, M.D., co-author of "Bypassing Bypass", claims chelation therapy results in a 75 to 95 percent success rate in improving blood flow in patients with clogged arteries. His book also quotes:

Henry Macintosh M.D: "bypass surgery should be limited to patients with crippling angina, for whom more conservative therapies were ineffective."
Dr. Nortin Hadler M.D.: a professor of medicine at the University of North Carolina “only three to five percent of the 300,000 bypasses performed in the U.S. were actually necessary.”